In contrast, EYA1 induces cyclin D1 through its phosphatase activity in breast cancer, and SIX1 directly enhances the transcription of cyclin D1 in rhabdomyosarcoma tumor cells [31, 36]. Here, SIX1 is linked to breast cancer.